Clinical Trials Logo

Medication Adherence clinical trials

View clinical trials related to Medication Adherence.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05892120 Enrolling by invitation - Clinical trials for Medication Adherence

A Smartphone App on Medication Adherence

App
Start date: June 1, 2023
Phase:
Study type: Observational [Patient Registry]

This is an experimental study which aims to explore the effectiveness of a smartphone app for medication adherence (MedAdhere app) among schizophrenic patients for eight weeks.

NCT ID: NCT05742685 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 2

Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

REINFORCE2
Start date: August 23, 2023
Phase: N/A
Study type: Interventional

Reinforcement learning is an advanced analytic method that discovers each individual's pattern of responsiveness by observing their actions and then implements a personalized strategy to optimize individuals' behaviors using trial and error. The goal of the proposed research is to refine, adapt and perform efficacy testing of a novel reinforcement learning-based text messaging intervention to support medication adherence for patients with type 2 diabetes within a community health center setting. This study will be a parallel randomized pragmatic trial comparing medication adherence and clinical outcomes for adults in a community setting aged 18-84 with type 2 diabetes who are prescribed 1-3 daily oral medications for this disease. Participants will be randomized to one of two arms for the duration of the study period: (1) a reinforcement learning intervention arm with up to daily, tailored text messages based on time-varying treatment-response patterns; or (2) a control arm with up to daily, un-tailored text messages. Outcomes of interest will be medication adherence, as measured by electronic pill bottles, and HbA1c levels over 6 months.

NCT ID: NCT05475431 Enrolling by invitation - Clinical trials for Helicobacter Pylori Infection

Real-world Treatment of H. Pylori Eradication in Patients With Comorbidity

Real-world_Hp
Start date: May 6, 2020
Phase:
Study type: Observational

Most of the studies of H. pylori eradication were conducted in academic institutes and designed to enrolled patients who did not have comorbidities. However, patients in the real world may comorbid with diabetes, chronic obstructive pulmonary disease, cirrhosis, chronic kidney diseases, or others. We hypothesize that the eradication rate of H. pylori in patients with comorbidity is poor because they may be infected with antibiotics-resistant H. pylori strains or have poor medication adherence. Here, we design a study, which focus on the H. pylori eradication rates by the various regimens in the real world, especially for those with high Charlson scores. It is presumed that our data will be helpful with regard to treating such patients with H. pylori eradication in the clinical scenario.

NCT ID: NCT05352061 Enrolling by invitation - Clinical trials for Medication Adherence

Addressing Psychosocial Comorbidities in HIV Treatment and Prevention 2b

Synk2b
Start date: August 15, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about ways to better support people living with HIV with their HIV treatment and cope with mental health challenges and/or substance use concerns.

NCT ID: NCT05235620 Enrolling by invitation - Clinical trials for Medication Adherence

Evaluation of PatientToc in Community Pharmacies

Start date: July 1, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate the initial "spread and scale" of PatientToc™, a patient-reported outcomes (PROs) collection software, to community pharmacies for the collection and use of PROs data pertaining to medication adherence. The investigators are doing this by engaging PatientToc™ and pharmacy partners in two plan-do-study-act (PDSA) cycles to implement and refine PatientToc™ and an implementation toolkit (i.e., supports/resource tools) within a small number of community pharmacies. Investigators will then scale implementation to more community pharmacies in a rigorous theory-driven evaluation of PatientToc™ implementation using interviews, self-reported data from the pharmacy, observations, and administrative data. Collectively, the findings will inform long-term collection and use of PROs data pertaining to medication use.

NCT ID: NCT05131074 Enrolling by invitation - Hypertension Clinical Trials

Collabree: A Remote Intervention to Improve the Regularity of Medication Intake

Start date: March 10, 2022
Phase: N/A
Study type: Interventional

This is a clinical study to improve the regularity of medication intake for high blood pressure. Adult women and men who are over 50 years old, who have received a prescription drug for high blood pressure from MediService, and who have to take at least 4 tablets per day (of which at least 1 dose of medication per day is for high blood pressure) can participate in this study. The investigators intend to examine whether Collabree, a mobile phone application, is effective in supporting patients with hypertension to more successfully following their therapy plan in order to improve the regularity of medication intake. The study includes a 90-day intervention phase and a 90-day follow-up. The study does not require any therapy adjustments and no visits to a study center are necessary. The participants conduct the study independently at home. Participants will also fill out questionnaires. Participants are randomly assigned to one of 3 groups in a ratio of 1: 1: 1. Two of these groups will receive the Collabree mobile phone application.

NCT ID: NCT03760211 Enrolling by invitation - HIV/AIDS Clinical Trials

A Mobile Gaming App to Improve ART Adherence for Youth

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Despite the need for consistent adherence to medical care, youth living with HIV have low rates of adherence to medications and treatment. There are few interventions to improve adherence to HIV medications and treatment for youth, and there is a great need for novel approaches that are engaging for this age group. The investigators developed an intervention that includes a mobile gaming app that is integrated with a 7-day electronic medication device and text messages. During gameplay, youth fight HIV in colorful organ systems. A small previous project found that the intervention helped youth who were newly starting medications for HIV by improving adherence and decreasing HIV virus in their bodies (viral load). This proposed project will test the intervention with larger number of youth (100) who are newly starting HIV treatment and medications in New England, Georgia, and in Mississippi. The investigators want to determine if adherence is improved and viral load is reduced in this larger sample.